3DPOD 216: Glynn Fletcher, EOS North America President
Glynn Fletcher is the President of EOS North America. Transitioning from the machine tool world to 3D printing has given him a unique perspective compared to many others in our industry. He is outspoken, direct, and clear in his views on both the immediate and long-term future of the industry. In this episode of the 3DPOD, we spoke with Glynn about the past, the current state of the market, downturns, and a hopeful future. He is very positive about the near-term outlook for EOS and optimistic about the long-term prospects for the industry. Strap in for this fun ride.
Podcast: Play in new window | Download
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
Children’s Nebraska Joins Insight Surgery to Bring 3D Printing to the OR
Children’s Nebraska is teaming up with UK-based Insight Surgery to bring personalized surgical planning and device manufacturing in-house. This move could reshape how the hospital prepares for complex procedures. By...
Insight Surgery Receives $2.5 Million Investment & FDA Clearance for 3D Printed Guides
UK-based Insight Surgery has received a $2.5 million investment, with the round led by medtech investor Nodenza Venture Partners. Insight has a workflow solution for end-to-end design and printing of...
3D Printed Skin: Australia Leads the World with Breakthrough Trial in Sydney
A world-first clinical trial is underway in Sydney, and it’s rewriting the future of burn treatment. At the Concord Burns Unit, a patient has become the first in the world...
Lithoz 3D Printed Bioceramic Implants Get a Boost from KLS Martin
Bioceramic implants could unleash a revolution. Ceramics that come close to mimicking bone could, if deemed safe and useful, replace a lot of metal and polymer implants. Now, a long...
